This paper provides an overview of the continuous processing landscape from dealing with FDA to the intricacies of continuous chemical reactions. The authors, from Pfizer Inc.s Pharmaceutical Sciences division, say the industry will change dramatically in the next decade.
AUTHOR: MATTHEW J. MOLLAN JR., PH.D. AND MAYUR LODAYA, PH.D., PFIZER INC. | FILE TYPE: MS WORD DOCUMENT
DOWNLOAD LINK
1-s2-0-s0378517312007764-mainDownload
The pharmaceutical industry has adopted roller compaction due to its significant advantage in production process efficiency and its applicability...
University of Manchester scientists have used graphene to target and neutralise cancer stem cells while not harming other cells....
Abstract While polymer strip films have garnered significant attention for their patient compliance and cost-effective scale-up, recent studies have...
With this book as their guide, readers have access to all the current information needed to thoroughly investigate and...
The quality by design (QbD) initiative is promoting a better understanding of excipient performance and the identification of critical...
© Interactive Pharm 2022
